Brief: Cellect Biotechnology Reports Q3 Loss Per Share $0.001

Quoin Pharmaceuticals

20/11/2020 13:03

Nov 20 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS THIRD QUARTER FINANCIAL AND
OPERATING RESULTS; RECENT DEVELOPMENTS POSITION COMPANY TO
ACCELERATE PROGRESS IN 2021
    * Q3 LOSS PER SHARE $0.001
    * COMPANY'S CASH AND CASH EQUIVALENTS TOTALED $6.07 MILLION
AS OF
SEPTEMBER 30, 2020
    * HAS SUFFICIENT FUNDS TO OPERATE IN NEXT 15 MONTHS

Source text for Eikon:  ID:nGNX8BsfMy 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))